Tractocile

Tractocile

atosiban

Manufacturer:

Ferring

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Atosiban acetate
Indications/Uses
Inhibition of uterine contractions in the management of premature labour.
Dosage/Direction for Use
Initially, 6.75 mg via slow IV over 1 min, followed by continuous IV infusion at 18 mg/hr for 3 hr. Thereafter, administer 6 mg/hr via continuous IV infusion for max 45 hr or until uterine contractions subside.
Contraindications
Pregnancy <24 wk or >33 wk, premature rupture of the membranes after 30 wk of pregnancy, insufficient foetal growth or abnormal foetal heart rate, antepartum uterine haemorrhage that requires immediate delivery, eclampsia or severe preeclampsia requiring delivery, intrauterine foetal death, suspected intrauterine infection, placenta praevia, abruptio placenta, abnormal or high-risk pregnancy.
Special Precautions
Renal & hepatic dysfunction, abnormally positioned placenta, multiple pregnancy or pregnancy between 24-27 wk, small for gestational age foetus. Treatment may be repeated up to 3 more times w/ uterine contractions & foetal heart rate monitored during use. May cause postpartum bleeding.
Adverse Reactions
(In the mother) Nausea & vomiting, headache, dizziness, hot flushes, tachycardia, hypotension, inj site reactions, hyperglycemia, fever, insomnia, itch, rash, allergic reaction, postpartum bleeding.
ATC Classification
G02CX01 - atosiban ; Belongs to the class of other gynecologicals. Used to inhibit uncomplicated premature labour between 24 and 33 weeks of gestation.
Presentation/Packing
Form
Tractocile IV inj vial 7.5 mg/mL
Packing/Price
0.9 mL x 1's
Form
Tractocile IV infusion vial 7.5 mg/mL
Packing/Price
5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in